CICCARELLI, NICOLETTA
 Distribuzione geografica
Continente #
EU - Europa 1.788
AS - Asia 758
NA - Nord America 704
SA - Sud America 480
AF - Africa 35
OC - Oceania 3
Totale 3.768
Nazione #
RU - Federazione Russa 1.425
US - Stati Uniti d'America 676
BR - Brasile 386
SG - Singapore 253
VN - Vietnam 247
IT - Italia 163
CN - Cina 77
GB - Regno Unito 70
KR - Corea 48
HK - Hong Kong 40
FR - Francia 39
AR - Argentina 36
DE - Germania 29
EC - Ecuador 18
ID - Indonesia 16
IN - India 15
CO - Colombia 14
MX - Messico 14
PY - Paraguay 12
ZA - Sudafrica 11
AT - Austria 10
BD - Bangladesh 10
FI - Finlandia 10
PL - Polonia 9
IE - Irlanda 7
IQ - Iraq 7
CL - Cile 6
EG - Egitto 6
NL - Olanda 6
SE - Svezia 6
UA - Ucraina 6
CA - Canada 5
JO - Giordania 5
JP - Giappone 5
PE - Perù 5
TN - Tunisia 4
AU - Australia 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
NP - Nepal 3
PK - Pakistan 3
SA - Arabia Saudita 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
DZ - Algeria 2
ES - Italia 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
TZ - Tanzania 1
UG - Uganda 1
Totale 3.768
Città #
San Jose 143
Singapore 136
Moscow 131
Ashburn 113
Ho Chi Minh City 111
Santa Clara 69
Hanoi 53
London 53
The Dalles 53
Chicago 50
Seoul 48
Naples 47
Castelgomberto 38
Hong Kong 37
Secaucus 36
São Paulo 32
Rome 29
Beijing 24
Buffalo 16
Elk Grove Village 16
Los Angeles 16
Assago 14
Dallas 13
Yubileyny 13
Lauterbourg 12
Helsinki 10
Rio de Janeiro 10
Da Nang 9
Haiphong 9
Portsmouth 9
Dublin 8
Milan 8
New York 8
Nuremberg 8
Belo Horizonte 7
Bogotá 7
Buenos Aires 7
Campinas 7
Mumbai 7
Thái Bình 7
Biên Hòa 6
Brasília 6
Frankfurt am Main 6
Guayaquil 6
Hải Dương 6
Warsaw 6
Atlanta 5
Can Tho 5
Council Bluffs 5
Curitiba 5
Goiânia 5
Orem 5
Pasadena 5
Quito 5
Recife 5
Stockholm 5
Amman 4
Asunción 4
Brooklyn 4
Cagliari 4
Fortaleza 4
Guarulhos 4
Johannesburg 4
Kyiv 4
Lima 4
Manaus 4
Mexico City 4
Porto Alegre 4
Ribeirão Preto 4
Salerno 4
Salvador 4
San Francisco 4
Santiago 4
São José 4
Thái Nguyên 4
Tokyo 4
Uberlândia 4
Baghdad 3
Barbacena 3
Bertioga 3
Cabo Frio 3
Cairo 3
Dhaka 3
Juiz de Fora 3
Medellín 3
New Delhi 3
Osasco 3
Pelotas 3
Pinhais 3
Pontal 3
Santo André 3
Tunis 3
Araçatuba 2
Açailândia 2
Bauru 2
Bexley 2
Boardman 2
Boston 2
Boydton 2
Brescia 2
Totale 1.655
Nome #
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 113
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 109
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 107
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 104
Degenerative and Vascular Fluent Aphasia: Looking for Differences 101
The facial emotion recognition deficit in Parkinson’s disease: Implications of a visual scanning strategy 101
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 99
Cognitive reserve and neuropsychological functioning in older HIV-infected people 94
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 94
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 93
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 93
Efficacy and safety of treatment simplification to atazanavir/ritonavir1lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 92
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 92
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 92
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 91
Unilateral Spatial Neglect in Degenerative Brain Pathology 85
Baseline CD4+ T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 85
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 84
Effect of aging and human immunodeficiency virus infection on cognitive abilities 84
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 82
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 81
Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey 80
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 79
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 78
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 77
Primary progressive aphasia: Linguistic patterns and clinical variants 76
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 75
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 74
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 74
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 73
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial 73
Posterior AD-Type pathology: Cognitive subtypes emerging from a cluster analysis 72
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 72
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 72
The deficit for the word-class "verb" in corticobasal degeneration: Linguistic expression of the movement disorder? 72
Writing errors in primary progressive aphasia 70
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 68
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 68
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease 67
Liver fibrosis is associated with cognitive impairment in people living with HIV 67
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer’s disease, and Parkinson’s disease: An evaluation of the “cortical hypothesis” of NeuroAIDS 66
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients 66
Safety and feasibility of treatment simplification to atazanavir/ ritonavir1lamivudine in hiv-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors1atazanavir/ ritonavir with virological suppression (atazanavir and lamivudine for treatment simplification, atlas pilot study) 64
Revised central nervous system neuropenetrationeffectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 64
Semantic memory in object use 61
Sleep Disorders Are Associated with Mental Health, Quality of Life and Stigma in an Italian Cohort of People Living with HIV 58
Early neuropsychological screening and long-term functional outcome in a sample of patients affected by mild stroke: The ReSCog Project 55
Exploring the Feasibility of a Telematic Version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 23
Totale 3.820
Categoria #
all - tutte 17.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 2 0 1
2024/20252.128 1 2 171 17 59 155 1.068 357 104 37 38 119
2025/20261.688 117 143 287 531 60 27 114 142 160 107 0 0
Totale 3.820